Cempra Stock Price (NASDAQ:CEMP)

Add to My Stocks
$3.8 $0.08 (2.06%) CEMP stock closing price Apr 21, 2017 (Closing)
YOUR DAILY UPDATE ON
CEMP
Cempra
21 APR 2017
amigobulls logo
CEMP hand_up
CEMP vs S&P 500
Closing Price: Apr 21, 2017
CEMP
$3.8 ( -1.94%)
S&P 500
2348.7 ( -0.3%)
CEMP
52 Week Price Range
1 Year Return: -79.68%
Q4 Growth*
Excellent
Profitable ?
No
net image
2016 Q4 Net Loss
-654.7%
home image
Rating
CEMP POOR
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Cempra Snapshot Video

14 5 2

CEMP Stock Details

Prev Close* : $3.88
Market Cap:
$199.09M
Day Low: $3.75
52 Week Low: $2.55
Open: $3.9
Volume: 435930
Day High: $3.95
52 Week High: $26.95
Dividend:
N/A

Latest Stock Market News

Latest Articles

Cempra News - From Partners

CEMP Stockcharts

View CEMP PE ratio, PS ratio stocks charts and compare with peers.
CEMP Chart
Note: Compare Cempra stock price history with the index and industry peers.

Cempra Valuation

PS ratio (
price to sales ratio
)
11.05
PB ratio (
price to book ratio
)
1.1

Cempra Financial Ratios

Asset Turnover
0.13
Receivables Turnover
3.44
Debt to Equity
0.08

CEMP Industry Peers

Company Price Change (%)
Biocardia Inc (BCDA)0.410 (0%)
Aratana Therapeutics (PETX)6.160.29 (4.94%)
Merck (MRK)61.890.66 (1.06%)
Pfizer (PFE)33.640.1 (0.3%)
Paratek Pharma (PRTK)220.4 (1.85%)
The Medicines Company (MDCO)51.831.06 (2%)
Emergent Biosolutions (EBS)28.570.53 (1.82%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aratana Therapeutics (PETX)6.160.29 (4.94%)
Redhill Biopharma (RDHL)10.380.41 (4.11%)
Ionis Pharma (IONS)44.261.35 (3.15%)
Spectrum Pharma (SPPI)7.090.12 (1.72%)
PTC Therapeutics (PTCT)11.370.12 (1.07%)
Nutraceutical International (NUTR)29.90.2 (0.67%)
Arrowhead Pharma (ARWR)1.520.01 (0.66%)
Top gainers from Medical-Drugs industry
* As of Apr 22, 2017
CompanyPriceChange (%)
Corcept Therapeutics (CORT)9.110.88 (8.81%)
AcelRx Pharma (ACRX)2.550.15 (5.56%)
Rigel Pharma (RIGL)2.870.16 (5.28%)
Cumberland Pharma (CPIX)5.940.31 (4.96%)
Galectin Therapeutics (GALT)3.090.14 (4.33%)
Aralez Pharma (ARLZ)1.570.07 (4.27%)
Valeant Pharmaceuticals Intl Inc (VRX)8.510.37 (4.17%)
Top losers from Medical-Drugs industry
* As of Apr 22, 2017

Cempra Inc Stock News - Partner Headlines

Cempra Financial Statements

income statement20162015201420132012
Net Sales Or Revenues18.01M27.3M15.21M7.81M-
Net Income-117.96M-91.11M-61.64M-45.03M-24.22M
Total Operating Expense135.21M116.22M74.6M50.72M22.92M
view Cempra Inc income statement
balance sheet20162015201420132012
Total Assets238.51M162.13M105.31M99M70.73M
Total Liabilities55.16M44.47M44.28M29.03M12.96M
Shareholders Equity183.34M117.66M61.02M69.97M57.77M
view Cempra Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities16.43M-3.24M8.72M8.47M-0.86M
Net Cash From (Used By) Operating Activities-87.08M-87.84M-49.09M-32.44M-23.1M
Increase (Decrease) In Prop Plant And Equipment-0.01M-0.04M-0.05M-0.13M-0.01M
view Cempra Inc cashflow statement

Cempra Stock Message Board

An investor needs to spend 3.8 to buy CEMP stock, as the closing Cempra stock price is 3.8. The total market value as denoted by 203.02M for Cempra, is the market value of the company's outstanding shares. Cempra valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy CEMP stock than sell it, then Cempra stock price goes up. Conversely, if more investors wanted to sell CEMP stock than buy it, there would be greater supply than demand, and the stock price would fall. 435930 CEMP shares were traded yesterday, and Cempra stock chart shows that the CEMP stock quote hit a day high of 3.95 and day low of 3.75. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Cempra stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.